Losing a significant amount of weight — whether through a GLP-1 medication, diet changes, or a combination of approaches — doesn’t always produce the body composition people picture beforehand. It’s a common enough experience that it has its own informal shorthand (“skinny fat”), and it’s worth understanding why it happens and what factors are associated with a more favorable outcome.
Why the scale number and the mirror don’t always match
Weight loss isn’t the same as fat loss. Any calorie deficit — including the reduced intake that typically accompanies GLP-1 medications like semaglutide or tirzepatide — causes the body to lose some combination of fat mass and lean mass (muscle). Clinical research on GLP-1 medications, including trial data summarized by the New England Journal of Medicine and reviewed by the National Institutes of Health, has found that a meaningful share of total weight lost during treatment can come from lean mass rather than fat alone, particularly when weight loss is rapid or protein intake and resistance exercise aren’t part of the picture. Losing muscle alongside fat can leave someone at a lower number on the scale but with a softer, less toned appearance than they expected — the “skinny fat” look people describe.
Factors associated with better body composition outcomes
Several factors are consistently associated with preserving more muscle during weight loss, according to guidance from the Harvard T.H. Chan School of Public Health and the National Institute of Diabetes and Digestive and Kidney Diseases:
Resistance training. Regular strength training during a weight-loss period signals to the body to preserve muscle rather than break it down for energy. This is one of the most consistently cited strategies for improving body composition outcomes during any significant weight loss, including GLP-1-assisted weight loss.
Adequate protein intake. Higher protein intake relative to total calories — within levels appropriate for the individual and any relevant health conditions — is associated with better lean mass retention during a calorie deficit. Appetite suppression from GLP-1 medications can sometimes make it harder to hit protein targets simply because overall food intake drops, which is worth discussing with a prescriber or dietitian.
Pace of weight loss. Very rapid weight loss is generally associated with a higher proportion of lean mass loss compared to more gradual loss, per general clinical nutrition guidance — another reason weight-loss pace is something to discuss with the prescribing clinician rather than adjust independently.
Skin elasticity is a separate issue. Loose or excess skin after weight loss is related to skin elasticity — influenced by age, genetics, how much weight was lost, and how quickly — rather than muscle mass, and doesn’t reliably resolve with exercise alone. For significant excess skin that doesn’t improve over time, a dermatologist or plastic surgeon can discuss options.
The takeaway
A GLP-1 medication changes appetite and intake, but it doesn’t automatically dictate what kind of body composition you end up with — that’s shaped by what happens alongside the medication, especially strength training and protein intake. Some research also suggests that combining GLP-1 therapy with structured resistance exercise leads to better preservation of lean mass than medication alone, though individual results vary and more long-term data is still emerging.
This article is for general educational purposes only and is not medical or nutrition advice. Don’t start, stop, or adjust a GLP-1 medication or its dosing on your own — any changes to your treatment plan, exercise routine, or protein targets should be discussed with your prescribing clinician or a registered dietitian, particularly if you have other health conditions.
— Gemifys
